Nanobodies targeting the interaction interface of programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-1/PD-L1)

Wen, BY; Zhao, L; Wang, YC; Qiu, CN; Xu, ZM; Huang, KL; Zhu, H; Li, ZM; Li, HJ

Li, HJ (reprint author), Guangdong Pharmaceut Univ, Sch Biosci & Biopharmaceut, Guangdong Prov Key Lab Biotechnol Candidate Drug, Guangzhou Higher Educ Mega Ctr, 280 Waihuan East Rd, Guangzhou 510006, Guangdong, Peoples R China.

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, 0; ():

Abstract

Targeting the interaction interface is an effective strategy to obtain programmed death receptor 1 (PD-1)/PD-1 ligand 1 (PD-L1) nanobody blockers. To ......

Full Text Link